Factors influencing the in vitro production of a myocardial depressant factor.
D000681:Amylases / Q000032:analysis; D000693:Anaerobiosis; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D002403:Cathepsins / Q000032:analysis; D002415:Cats; D002458:Cell Fractionation; D002729:Chloromercuribenzoates / Q000494:pharmacology; D002854:Chromatography, Paper; D003594:Cytoplasmic Granules / Q000201:enzymology; D005260:Female; D006321:Heart / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D009994:Osmolar Concentration; D010179:Pancreas / Q000166:cytology / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D013347:Subcellular Fractions / Q000187:drug effects / Q000201:enzymology; D013385:Succinate Dehydrogenase / Q000032:analysis; D014357:Trypsin / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D002729:Chloromercuribenzoates; D013385:Succinate Dehydrogenase; D000681:Amylases; D002403:Cathepsins; D014357:Trypsin